Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Calliditas Therapeutics AB

Closing information (x1000 DKK)

Closing information 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Turnover 536,510 Less Arrow 166,765 Less Arrow 648
Financial expenses 25,172 Less Arrow 6,728 More Arrow 42,230
Earnings before taxes -273,586 Less Arrow -373,290 More Arrow -323,258
EBITDA -273,327 Less Arrow -381,348 More Arrow -279,341
Total assets 1,305,041 Less Arrow 1,061,546 More Arrow 1,116,521
Current assets 943,682 Less Arrow 736,418 More Arrow 768,473
Current liabilities 217,329 Less Arrow 98,487 Less Arrow 78,281
Equity capital 512,042 More Arrow 733,153 More Arrow 897,168
- share capital 1,592 Less Arrow 1,523 Less Arrow 1,481
Employees (average) 86 Less Arrow 56 Less Arrow 23

Financial ratios

Fiscal year 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Solvency 39.2% More Arrow 69.1% More Arrow 80.4%
Turnover per employee 6,238 Less Arrow 2,978 Less Arrow 28
Profit as a percentage of turnover -51.0% Less Arrow -223.8% Less Arrow -49885.5%
Return on assets (ROA) -19.0% Less Arrow -34.5% More Arrow -25.2%
Current ratio 434.2% More Arrow 747.7% More Arrow 981.7%
Return on equity (ROE) -53.4% More Arrow -50.9% More Arrow -36.0%
Change turnover 383,253 Less Arrow 166,130 Less Arrow -136,340
Change turnover % 250% More Arrow 26141% Less Arrow -100%
Chg. No. of employees 30 More Arrow 33 Less Arrow 9
Chg. No. of employees % 54% More Arrow 143% Less Arrow 64%

Total value of public sale

Fiscal year 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.